<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ — Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/NVAX Contact An Attorney Now: NVAX@hbsslaw.com 844-916-0895 Novavax, Inc. (NVAX) Investigation: The U.S. government invested approximately $1.6 billion in Novavax in 2020 in the hopes it would offer a safe and effective vaccine to help protect against COVID-19.
...read full article on PRNewsWire
